|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Letter |
Norma J. Vinger Center for Breast Care Gundersen Lutheran Health System La Crosse, WI 54601
WEB—This is a Web exclusive article.
The impact of mammography service screening on mortality from breast cancer in women who attend screening can be predicted by thorough analysis of the reliable surrogate measures, such as tumor size and node status [2]. These parameters will enable us to estimate whether a significant decrease in the advanced breast cancer rate has been achieved, a prerequisite for the subsequent, significant mortality reduction in women who attend screening regularly.
Although recall rate, sensitivity, cancer detection rate, positive predictive value, and false-negative rate are additional important performance measures when evaluating mam mography service screening, without reporting the tumor size and node status of all screening-detected and interval cancers, we will not have an accurate metric for predicting the effect on patient morbidity and mortality. At a minimum, the following performance parameters will be required to assess the long-term effect of the mammography screening: cancer detection rate in screening according to 10-year age subgroups, invasive-to-noninvasive cancer ratio, mean and median size of invasive cancers, node positivity rate, recall rate, sensitivity, and specificity.
In addition, it is extremely important to perform a similar audit on the cancers de tected in the interscreening interval (i.e., cancers detected within 11 months of a BI-RADS assessment category 1 or 2 [3] screening mammography finding): invasive-to-noninvasive cancer ratio, mean and median size of invasive cancers, and node positivity rate. These parameters will be vital for comparing the performance of different screening inter pre tation methods (single reader, double reader, and single reader with CAD).
Second, experience alone does not provide an objective measure of performance. Therefore, it is necessary to list the objective screening mammography performance parameters for each interpreting radiologist involved in mammography service screening.
Lastly, the potential value of CAD is inversely proportional to the expertise of the radiologist performing mammography screening.
References
This article has been cited by other articles:
![]() |
M. Gromet Reply Am. J. Roentgenol., November 1, 2008; 191(5): W205 - W205. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |